Immunome Inc.·4

Jul 31, 7:00 PM ET

Tsai Philip 4

4 · Immunome Inc. · Filed Jul 31, 2025

Insider Transaction Report

Form 4
Period: 2025-07-29
Tsai Philip
Chief Technology Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-07-29+190,000190,000 total
    Exercise: $10.60Exp: 2035-07-28Common Stock (190,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.

Documents

1 file
  • 4
    form4-07312025_110740.xmlPrimary